Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Micheline Karam"'
Autor:
Micheline Karam, Maguy Pereira, Alyette Vasseur, Ibrahim Yakoub-Agha, Florence Broussais, Delphine Chaillou, Nicole Raus
Publikováno v:
Bulletin du Cancer. 108:S82-S86
Tisagenlecleucel (Kymriah™) and axicabtagene ciloleucel (Yescarta™) are the first representatives of a new class of gene therapies produced by ex-vivo genetic modification of human autologous T lymphocytes, now using viral vectors. In 2020, there
Autor:
Mathilde Sourisseau, Emmanuel Faure, Hélène Béhal, Paul Chauvet, Micha Srour, Antoine Capes, Valérie Coiteux, Léonardo Magro, Serge Alfandari, Enagnon Kazali Alidjinou, Nicolas Simon, Fanny Vuotto, Micheline Karam, Karine Faure, Ibrahim Yakoub-Agha, David Beauvais
Publikováno v:
Blood Advances
Blood Advances, 2022, Blood Advances, 7 (5), pp.856-865. ⟨10.1182/bloodadvances.2022008667⟩
Blood Advances, 2022, Blood Advances, 7 (5), pp.856-865. ⟨10.1182/bloodadvances.2022008667⟩
Letermovir is the first approved drug for cytomegalovirus (CMV) infection prophylaxis in adult CMV-positive patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT). Since CMV infection risk varies from patient to patient, we eval
Autor:
Micheline Karam, Maguy Pereira, Carole Dantin, Elodie Colonnese, Christelle Latiere, Delphine Chaillou, Alyette Vasseur, Ibrahim Yakoub-Agha, Christian Chabannon, Youcef Meziane, Nicole Raus
Publikováno v:
Bulletin du Cancer. 107:S178-S184
Resume Tisagenlecleucel (Kymriah™) et axicabtagene ciloleucel (Yescarta™) sont les premiers representants d’une nouvelle classe de therapies cellulaires produites par modification genetique ex vivo de lymphocytes T autologues humains, aujourd
Autor:
Carole Dantin, Micheline Karam, Ibrahim Yakoub-Agha, Nicole Raus, Maguy Pereira, Anne Wallart, Réda Chebel, Micha Srour
Publikováno v:
Bulletin du Cancer. 107:S52-S61
In an effort to standardize hematopoietic stem cell allograft procedures, the Francophone bone marrow transplantation and Cell Therapy Society (SFGM-TC) organized the 9th Allograft Harmonization Practice Workshop in Lille in September 2018. The purpo
Autor:
Severine Leroux, Jérôme Cornillon, Stéphanie Seris, Ibrahim Yakoub-Agha, Youcef Meziane, Sandrine Richard-Leveille, Nathalie Laurent, Laetitia Le Bars, Nicole Raus, Stephanie Marion, Denis Guyotat, Micheline Karam, Maguy Pereira, Marie Y. Detrait, Valérie Coiteux
Publikováno v:
Bulletin du Cancer. 106:S71-S82
The quality of the information provided in post-transplant follow-up is necessary to obtain a coherent and exploitable database. Since the beginning of 2017, three forms (Med-B-allograft) have been available: the first month (Day 0), Day 100 (second
Autor:
Florence, Broussais, Alyette, Vasseur, Micheline, Karam, Delphine, Chaillou, Maguy, Pereira, Ibrahim, Yakoub-Agha, Nicole, Raus
Publikováno v:
Bulletin du cancer. 108(12S)
Tisagenlecleucel (Kymriah™) and axicabtagene ciloleucel (Yescarta™) are the first representatives of a new class of gene therapies produced by ex-vivo genetic modification of human autologous T lymphocytes, now using viral vectors. In 2020, there
Autor:
Alyette, Vasseur, Micheline, Karam, Delphine, Chaillou, Elodie, Colonnese, Carole, Dantin, Christelle, Latiere, Youcef, Meziane, Maguy, Pereira, Ibrahim, Yakoub-Agha, Christian, Chabannon, Nicole, Raus
Publikováno v:
Bulletin du cancer. 107(12S)
Tisagenlecleucel (Kymriah™) and axicabtagene ciloleucel (Yescarta™) are the first two approved drug products that belong to of a new class of therapies manufactured through an industrial process that includes the ex vivo genetic modification of h
Autor:
Nicole, Raus, Micheline, Karam, Réda, Chebel, Carole, Dantin, Maguy, Pereira, Anne, Wallart, Ibrahim, Yakoub-Agha, Micha, Srour
Publikováno v:
Bulletin du cancer. 107(1S)
In an effort to standardize hematopoietic stem cell allograft procedures, the Francophone bone marrow transplantation and Cell Therapy Society (SFGM-TC) organized the 9th Allograft Harmonization Practice Workshop in Lille in September 2018. The purpo
Autor:
Jérôme, Cornillon, Marie, Detrait, Micheline, Karam, Laëtitia, Le Bars, Youcef, Meziane, Maguy, Pereira, Sandrine, Richard-Leveille, Stephanie, Marion, Severine, Leroux, Valérie, Coiteux, Nicole, Raus, Stéphanie, Seris, Denis, Guyotat, Ibrahim, Yakoub-Agha, Nathalie, Laurent
Publikováno v:
Bulletin du cancer. 106(1S)
The quality of the information provided in post-transplant follow-up is necessary to obtain a coherent and exploitable database. Since the beginning of 2017, three forms (Med-B-allograft) have been available: the first month (Day 0), Day 100 (second